(a) Equity interests in related parties
Equity interests in subsidiaries
Details of the percentage of ordinary shares held in subsidiaries are disclosed in note 22 to the fi nancial statements. (b) Key
(b)Key management personnel remuneration
Details of key management personnel remuneration are disclosed in note 4 to the fi nancial statements. \
(c) Key management personnel equity holdings
Fully paid ordinary shares of Rockeby biomed Ltd
Executive share options of Rockeby biomed Ltd
(d) Other transactions with key management personnel
The profit from operations includes items of revenue and expense that resulted from transactions other than remuneration, loans or equity holdings, with key management personnel or their personally-related entities and which are disclosed in Note 4 to the financial statements.
Included in the balance sheet at the year end is an inventory loan facility which is secured against the personal assets of Sze Wee Tan.
Subsequent to the year end, the Company has been granted access to $500,000 bank facility. The facility is secured against the personal assets of Sze Wee Tan.
(e) Transactions with other related parties
Other related parties include:
- entities with joint control or signifi cant infl uence over the consolidated entity;
- subsidiaries;
- other related parties.
Amounts receivable from and payable to these related parties are disclosed in notes 4 & 9 to the fi nancial statements.
On 30 June 2006, all intercompany debts were capitalised at the appropriate level within the Rockeby group. This resulted in an additional $8,778,998 being booked as an investment in the parent entity which was subsequently written off as an impairment adjustment. All loans advanced to and payable to related parties are unsecured and subordinate to other liabilities. No interest was charged on these loan balances during the year.
(f) Parent entities
The ultimate parent entity in the consolidated entity is Rockeby biomed Ltd.
